Terahertz-Based Porosity Measurement of Pharmaceutical Tablets: a Tutorial

No Thumbnail Available
Change log
Bawuah, P 
Markl, D 
Farrell, D 
Evans, M 
Portieri, A 

jats:titleAbstract</jats:title>jats:pPorosity, one of the important quality attributes of pharmaceutical tablets, directly affects the mechanical properties, the mass transport and hence tablet disintegration, dissolution and ultimately the bioavailability of an orally administered drug. The ability to accurately and quickly monitor the porosity of tablets during manufacture or during the manufacturing process will enable a greater assurance of product quality. This tutorial systematically outlines the steps involved in the terahertz-based measurement method that can be used to quantify the porosity of a tablet within seconds in a non-destructive and non-invasive manner. The terahertz-based porosity measurement can be performed using one of the three main methods, which are (i) the zero-porosity approximation (ZPA); (ii) the traditional Bruggeman effective medium approximation (TB-EMA); and (iii) the anisotropic Bruggeman effective medium approximation (AB-EMA). By using a set of batches of flat-faced and biconvex tablets as a case study, the three main methods are compared and contrasted. Overall, frequency-domain signal processing coupled with the AB-EMA method was found to be most suitable approach in terms of accuracy and robustness when predicting the porosity of tablets over a range of complexities and geometries. This tutorial aims to concisely outline all the necessary steps, precautions and unique advantages associated with the terahertz-based porosity measurement method.</jats:p>

Terahertz spectroscopy, Pharmaceutical tablet, Porosity, Effective medium approximation, Refractive index, Optical path length
Journal Title
Journal of Infrared, Millimeter, and Terahertz Waves
Conference Name
Journal ISSN
Volume Title
Springer Science and Business Media LLC
All rights reserved
Technology Strategy Board (104196)
Engineering and Physical Sciences Research Council (EP/P006965/1)